MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment

Clinical trial NCT05219734 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05219734
Sponsor: Invitae Corporation
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Cancer Solid Tumor Non Small Cell Lung Cancer Colorectal Cancer Bladder Cancer

Start date: 2021-11-29
Primary completion: 2026-12-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.